Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
10/2005
10/19/2005CN1682917A Astragalus root dripping pill and its preparing method
10/19/2005CN1682888A Chinese medicine for treating prostatitis
10/19/2005CN1682838A Medicine for treating lithiasis in urinary system
10/19/2005CN1682810A Prostate external application powder for treating prostatic diseases
10/19/2005CN1682808A Quick-acting prostate pill for treating prostatic diseases
10/19/2005CN1682798A Shenbao solid preparation good for kidney and its preparing method
10/19/2005CN1682796A Kidney invigorating medicine and its producing method
10/19/2005CN1682780A Medicine for treating uaemia and insufficiency of kidney-yang and kidney exhaustion and its preparing method
10/19/2005CN1682729A Fibrauretin dripping pill and its preparing method
10/19/2005CN1223591C Piperazine oxime derivatives having Nk-1 receptor antagonistic activity
10/19/2005CN1223358C Chinese medicinal herbs preparation for treating nephritic syndrome and its preparing method
10/19/2005CN1223356C Medicine for treating lithiasis
10/19/2005CN1223346C Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
10/18/2005US6956050 Imidazole compounds as anti-inflammatory and analgesic agents
10/18/2005US6956028 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging
10/18/2005CA2334702C Pharmaceutical compositions and uses for androst-5-ene-3.beta.,17.beta.-diol
10/18/2005CA2125730C Novel sulfonylamino pyrimidines
10/18/2005CA2046265C Sulphured imadazole derivatives, their preparation process, the new intermediates obtained, their application as drugs and the pharmaceutical preparations containing them
10/13/2005WO2005095604A1 Rf rp transgenic animal
10/13/2005WO2005095419A1 Thiazolopyrimidine derivative
10/13/2005WO2005095381A1 Dipeptidyl peptidase inhibitors
10/13/2005WO2005095276A1 Method for producing spherical activated carbon
10/13/2005WO2005094856A1 Preparation and therapeutic uses of plants and plant extracts in the hylocereus genus
10/13/2005WO2005094845A1 Adsorbent for oral administration, therapeutic or preventive agent for kidney disease, and therapeutic or preventive agent for liver disease
10/13/2005WO2005094844A1 Adsorbent for oral administration, preventive or remedy for kidney disease and preventive or remedy for liver disease
10/13/2005WO2005094813A1 Medicine for kidney disorder
10/13/2005US20050228180 Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers
10/13/2005US20050228170 B7-like molecules and uses thereof
10/13/2005US20050228036 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
10/13/2005US20050228001 Methods and compositions for treating platelet-related disorders
10/13/2005US20050227991 Containing a piperazine ring, e.g., N'-(4-{4-[5-(1,2-dithiolan-3-yl)pentanoyl]-1-piperazinyl)phenyl)-2-thiophenecarboximidamide and intermediates for preparing them; useful for inhibiting NO synthase and regenerating antioxidants
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227978 Fibrosis inhibitor
10/13/2005US20050227973 Human adam-10 inhibitors
10/13/2005US20050227972 treating disorders of the cardiovascular system; adenosine receptor agonists/antagonists
10/13/2005US20050227916 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/13/2005US20050227280 Proteases
10/13/2005US20050226859 Peg-Modified Uricase
10/13/2005CA2562700A1 Novel pharmaceutical compositions
10/13/2005CA2562144A1 Process for manufacturing spherical activated carbon
10/13/2005CA2561731A1 Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease
10/13/2005CA2561730A1 Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease
10/13/2005CA2557372A1 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
10/12/2005EP1584925A1 Novel screening method
10/12/2005EP1583763A1 Benzoazolypiperazine derivatives having mglur1- and mglur5-antagonistic activity
10/12/2005EP1583741A1 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
10/12/2005EP1494659B1 Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amide and lactic acid or a lactic acid salt
10/12/2005EP1150982B1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkB-alpha
10/12/2005EP0946170B1 Diclofenac for the treatment of vasculopathies
10/12/2005CN1681818A Azaindole kinase inhibitors
10/12/2005CN1681811A Azolidinone-vinyl fused-benzene derivatives
10/12/2005CN1681806A Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic
10/12/2005CN1681795A Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/12/2005CN1681784A Azabicyclo derivatives as muscarinic receptor antagonists
10/12/2005CN1681775A N-hydroxyformamidine derivative
10/12/2005CN1681770A Amino-propanol derivatives
10/12/2005CN1681557A Methods for treating carbonic anhydrase mediated disorders
10/12/2005CN1681527A Therapies for renal failure using interferon-beta
10/12/2005CN1681514A A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus
10/12/2005CN1681508A Novel inhibitors of kinases
10/12/2005CN1681506A Use of a quinazoline derivative for treating lower urinary tract symptoms
10/12/2005CN1681492A Combinations of atorvastatin and alpha1adrenergic receptor antagonists
10/12/2005CN1681488A Drug for kidney failure containing oxaluric acid derivative
10/12/2005CN1680378A Pyrazolo(4, 3-d)pyrimidine derivatives
10/12/2005CN1680371A Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds
10/12/2005CN1680358A Composition concerned with isoflavone and the similar and therapeutical method
10/12/2005CN1680341A Valsartan salts
10/12/2005CN1680324A Dihydropyridine soft drugs, and related compositions and methods
10/12/2005CN1679942A Compound preparation of aspirin and ginkgo biloba extract and use thereof
10/12/2005CN1679935A Method for treating fibrosis by utilizing integrin alpha 4 subunit antagonist
10/12/2005CN1679914A Medicinal composition of induced glutathione and ebeselen
10/12/2005CN1679906A Chinese medicine for treating atrophic gastritis, atrophic hepatitis and atrophic nephropathy and production thereof
10/12/2005CN1679888A Decoction Chinese medicine sterilizing antiphlogistic, preparation and use thereof
10/12/2005CN1679857A Chinese medicine composition for treating lithiasis and preparation thereof
10/12/2005CN1679834A Capsules of Tokyo violet, dandelion and flavescent sophora root and their making method
10/12/2005CN1679807A Heat-clearing and stranguria-relieving Chinese medicine preparation and production thereof
10/12/2005CN1679802A Preparation of strengthening waist and health-caring kidney and its making method
10/12/2005CN1679798A Biological medicine with metabolic treatment and production thereof
10/12/2005CN1679779A Chinese medicine preparation for treating hepatonephric disease, preparation and quality control thereof
10/12/2005CN1679757A Capsules of Relinqing
10/12/2005CN1679734A Chinese medicine composition for treating prostatitis and preparation thereof
10/12/2005CN1679686A Capsules for treating prostatic disease
10/12/2005CN1679676A Six-component saf-flower drops and preparation thereof
10/12/2005CN1679608A Compound preparation of inosine, triphosphoadenosine and vitamin C and use thereof
10/12/2005CN1679590A Ethinyl estradiol gas permeable absorbing gel
10/12/2005CN1679564A Method of treating of demyelinating diseases or conditions
10/12/2005CN1679556A Valdecoxib compositions
10/12/2005CN1679552A Preferential inhibition of release of pro-inflammatory cytokines
10/12/2005CN1679532A Therapeutic and dietary compositions
10/12/2005CN1222527C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
10/12/2005CN1222523C 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
10/12/2005CN1222520C Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
10/12/2005CN1222510C Novel benzoylguanidine salt
10/12/2005CN1222288C Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
10/11/2005US6953853 Phospholipase inhbitors; antiinflammatory agents; respiratory system disorders
10/11/2005US6953810 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
10/11/2005US6953809 Monocyte chemoattractant protein-1 inhibitor compounds
10/11/2005US6953796 Use of 2-amino-thiazoline derivatives as inhibitors of inducible No-synthase
10/11/2005US6953791 Dipeptide derivatives
10/11/2005US6953787 5HT2C receptor modulators
1 ... 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 ... 562